葉酸ケージ型PROTACによるがん選択的標的分解
1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States.
Journal of the American Chemical Society
|May 10, 2021
まとめ
この研究では,がん治療のための葉酸結合タンパク質分解標的キメラ (PROTACs) が導入されました. これらの新しいPROTACは,がん細胞の標的タンパク質を選択的に分解し,正常な組織における毒性を減少させます.
科学分野:
- 生物化学
- 分子生物学
- 薬物の発見
背景:
- タンパク質分解標的キメラ (PROTACs) は,ユビキチン- プロテアゾーム系を通じて細胞内タンパク質を分解する.
- PROTACsによる組織外分解は毒性を引き起こし,臨床使用を制限する.
- 副作用を最小限に抑えるには,組織選択的なPROTACの活性が不可欠です.
研究 の 目的:
- PROTACsのがん細胞選択的投与戦略を開発する.
- 癌細胞のタンパク質分解を狙い,正常な細胞を助長する.
- 選択的な PROTAC アプリケーションの汎用性のあるプラットフォームを作成します.
主な方法:
- 葉酸群をVHL E3リガゼリガンドと結合して葉酸-PROTACを作ります.
- BRD,MEK,ALK (葉酸ARV-771,葉酸MS432,葉酸MS99) を標的とした特定のPROTACの開発.
- 癌細胞における葉酸受容体依存タンパク質の分解を評価する.
主要な成果:
- 葉酸PROTACは,標的タンパク質の癌細胞選択的分解を示した.
- BRD,MEK,ALKの分解は葉酸受容体に依存した方法で観察されました.
- この戦略は,がん細胞における関心のあるタンパク質 (POI) を成功裏に標的とした.
結論:
- 葉酸結合により,選択的にPROTACを癌細胞に投与することができる.
- このアプローチは,腫瘍学における標的型タンパク質分解のための多用途のプラットフォームを提供します.
- 開発された葉酸PROTACは より安全で効果的ながん治療の可能性を示しています
関連する概念動画
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
Drugs that Destabilize Microtubules
2.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.2K
Drugs that Stabilize Microtubules
2.3K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.5K
Combination Therapies and Personalized Medicine
5.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K
Cancer Therapies
8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K


